Targeted Oncology24m
Response Time and BRAF Status Factor Into IO Selection for Melanoma
During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed how data from the CheckMate-067 and RELATIVITY-047 ...
CORRECTING and REPLACING New Data Reveals DCT Components Linked to Improvements in Clinical Trial Access Among Underrepresented Communities
Please replace the release dated Jan. 28, 2025 with the following corrected version due to multiple revisions.